Type I poliovirus isolated in 4 migrant children with paralysis
Ruffault, A.; Hegaret, A.; Fauconnier, B.
La Nouvelle Presse Medicale 7(24): 2174-2175
1978
ISSN/ISBN: 0301-1518 PMID: 210443 Document Number: 136307
Document emailed within 1 workday
Related Documents
Szczepski, O.; Wlodarczak, K.; Walczak, M.; Walter, Z.; Klauziński, R. 1970: Immunoglobulin level in the saliva of children with poliomyelitis and healthy children following oral vaccination with live attenuatea strain of type 2 and 3 poliovirus Polski Tygodnik Lekarski 25(8): 281-283Wang, D.; Xu, Y.; Zhang, Y.; Zhu, S.; Si, Y.; Yan, D.; Zhu, H.; Yang, Q.; Ji, T.; Xu, W. 2016: Genetic Characteristics of Coxsackievirus Group a Type 4 Isolated from Patients with Acute Flaccid Paralysis in Shaanxi, China Bing du Xue Bao 32(2): 145-149
Boulloche, J.; Slim, S.; Le Luyer, B.; Mallet, E.; Tron, P.; Le Roux, P.; Lienhardt, P.Y.; Coudray, C. 1993: Isolated acute peripheral facial paralysis in children. Etiological and prognostic study Archives Francaises de Pediatrie 50(5): 387-389
Asghar, H.; Zaidi, S.S.; Ghafoor, A.; Anwer, F.; Gul, A.; Aurakzai, A. 1992: Isolation of wild type poliovirus type 1 from cerebrospinal fluid in sub-acute sclerosing panencephalitis Jpma. Journal of the Pakistan Medical Association 42(9): 231
Dol'nitskii, O.V.; Klimmenko, M.D. 1978: L'Episcopo's operation in the Duchenne-Erb type of brachial plexus birth paralysis in children Ortopediia Travmatologiia i Protezirovanie 7: 42-46
Hils, J.; Böthig, B. 1974: Adsorption and elution of poliovirus type 2 strains in Al (OH)3 gel Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 20(8): 529-530
McCarthy, M. 2014: Eradication of wild poliovirus type 3 may be within reach, say CDC and WHO Bmj 349: G6817
Liu, H.M.; Guo, C.S.; Wei, W.J. 1997: Studies on the molecular epidemiology of poliovirus type 1 in China Zhonghua Liu Xing Bing Xue Za Zhi 18(4): 208-210
Wang, X-Wen.; Sheng, W.; Zeng, Y. 2013: Formation and identification of virus-like particles of poliovirus type I Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 27(5): 373-375
Almond, J.W.; Stone, D.; Burke, K.; Skinner, M.A.; Macadam, A.J.; Wood, D.; Ferguson, M.; Minor, P.D. 1993: Approaches to the construction of new candidate poliovirus type 3 vaccine strains Developments in Biological Standardization 78: 161-169; Discussion: 169-170
Friedrich, F. 2000: Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus Acta Virologica 44(2): 109-117
Dowdle, W.R.; Wolff, C.; Sanders, R.; Lambert, S.; Best, M. 2004: Will containment of wild poliovirus in laboratories and inactivated poliovirus vaccine production sites be effective for global certification? Bulletin of the World Health Organization 82(1): 59-62
Chowdhary, R.; Dhole, T.N. 2008: Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India Journal of Medical Virology 80(8): 1477-1488
Tomaszewska, J.; Milanowska, K. 1971: Clinical peculiarities of the epidemic of poliomyelitis caused by type 3 of poliovirus in 1968 Polski Tygodnik Lekarski 26(13): 469-470
Deshpande, J.M.; Dave, K.H. 1987: Intratypic serodifferentiation of poliovirus type 1 isolates using kinetic neutralization test Indian Journal of Medical Research 86: 419-422
Senouci, S.; Maul, A.; Schwartzbrod, L. 1996: Comparison study on three protocols used to concentrate poliovirus type 1 from drinking water Zentralblatt für Hygiene und Umweltmedizin 198(4): 307-317
Cravioto, A.; Vázquez, V.; Soria, A.; Navarro, A.; Ortiz, M. 1988: Production of Shiga-1-type (SLT) cytotoxin in strains of Escherichia coli isolated from children with diarrhea in a rural community Boletin Medico del Hospital Infantil de Mexico 45(4): 206-210
Baicuş, A.; Combiescu, M.; Persu, A.; Aubert-Combiescu, A. 2006: Immune status to polioviruses in the child population of Romania between 2002-2005 as indicated by serological investigation in cases of acute flaccid paralysis (AFP) and facial paralysis (FP) and its use as a "national reference value" to evaluate the vaccination coverage in particular groups of healthy children Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 110(4): 1004-1011
Rumiantsev, A.A.; Grachev, V.P.; Kozlov, V.G.; Karganova, G.G. 2001: Use of molecular biological method (MAPREC-test) for evaluating residual neurovirulence and genetic stability of oral poliovirus vaccine type 3 Voprosy Virusologii 46(6): 11-15
John, T.Jacob.; Jain, H.; Ravishankar, K.; Amaresh, A.; Verma, H.; Deshpande, J.; Pallansch, M.A.; Singh, A.Pal.; Sreevatsava, M.; Burton, A.; Malankar, P.; Chatterjee, A.; Sutter, R.W. 2011: Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials Vaccine 29(34): 5793-5801